Oliver has more than 20 years of experience in the pharmaceutical, diagnostics and medical technology industries. He joins Imagion from TransCode Therapeutics, dedicated as its Vice President R&D focused on targeted, image-guided cancer detection and treatment. Prior experience during his time at PHILIPS includes the positions of Senior Director Clinical Research, governing the North America program and moving several products through the clinic and approval; as well as Senior Director Biomolecular Engineering leading diagnostic and interventional imaging developments. Oliver started in various R&D positions at ALTANA Pharma including building its US-innovation site ALTANA Research Institute. He received his PhD degree in biochemistry from the University of Tuebingen, Germany.